Jim Keegan Email & Phone Number

Colorado Springs, CO, US

Abundant family time; weekday skiing, hiking, and kayaking in beautiful Colorado

Yokneam, Israel, IL

• Executed all strategic planning, upstream marketing, and business development assessment for an early commercial startup focused in the neurovascular space.
• Designed and initiated implementation of detailed plans to introduce the company’s unique technology into the peripheral vascular space, including FDA and EUMDR submissions
• Leveraged my extensive network of KOLs in the PV field and engaged top consultants
• Analyzed and advised the CEO on potential merger/ acquisition opportunities
• Position eliminated when the company could no longer afford to invest in the program I was brought in to lead

Amsterdam, Noord-Holland, NL

• Orchestrated strategic planning processes across all business categories for Philips Image Guided Therapy Devices, a ~$900M global capital and disposable medical device business.
• Guided exploration of new spaces and partnered with Business Development on M&A activities.
• Performed modeling and commercial assessment for $275M Intact Vascular acquisition
• Prepared and delivered strategic plans and execution dialogues for IGT Cluster to Philips Executive Committee and CEO. Consistently rated #1 among Philips business units
• Member of IGTD Senior Management Team

Amsterdam, Noord-Holland, NL

• Led upstream and downstream marketing (team of 18 marketing professionals) for the combined legacy Volcano and Spectranetics Peripheral Vascular business; one of the fastest-growing units in Philips. Endovascular.
• Designed new organization including competency assessment and capability mapping to optimize upstream/downstream balance and enhance performance
• Devised and implemented our combined go-to-market strategy, field training program, and marketing plans resulting in 16% global growth in 2019

Colorado Springs, Colorado, US

• Directed downstream marketing team for rapidly-growing VI business featuring the Excimer laser console and the Turbo family of atherectomy catheters
• Directed strategic planning, multi-functional team preparation, and commercial execution for US launch of Stellarex Drug Coated Balloon, the most successful product launch in Spectranetics history and inspiration for.
• Delivered 2016 revenues at 103% to plan with double-digit growth
• Oversaw 2016 launch of Turbo-Power Excimer Laser Atherectomy Catheter; beat revenue goalsSpectranetics acquired by Philips in August 2017.

Murray Hill, New Jersey, US

• Led team of 23 marketing professionals across multiple functions, directing upstream and downstream marketing for Bard’s $500 million combined global Vascular Access Devices and Biopsy businesses as well as the.
• Drove global revenue growth in 2014 in a market enduring rapid price erosion
• Launched multiple new products and promotional programs in 2014
• Collaborated with Business Development team to complete a key Biopsy acquisition
• Managed $3 million Marketing Communications annual budget within plan

• Management Board position leading Product Management, Physician Education, and Marketing Communications as Biopsy/ Oncology business spun out as a new Bard division focused on breast biopsy and targeted radiation.
• Managed integration of SenoRx marketing team and functions following 2010 acquisition
• Drove global revenue growth of 31% in 2011, 2% in 2012, and 4% in 2013
• Led design inputs, launch strategy, campaign development, and launch execution for two major Biopsy system launches -- EnCor Enspire and EnCor Ultra
• Initiated BBS Physician Education program with first Radiology training course in 2013

Warwick, RI, US

• Managed full P&L responsibility for rapidly growing $70 million Biologics franchise with direct leadership over marketing/product management team and shared leadership over R&D
• Delivered 2010 revenue at 102% of budget and 168% of prior year
• Designed strategy for significant expansion of clinical and pre-clinical research programs
• Built research and development programs to deliver next generation, differentiated technologies
• Developed novel marketing and surgical education programs to expand presence in Plastic and Reconstructive Surgery market

Warwick, RI, US

• Directed team of seven marketing professionals in managing Davol’s flagship $260 million global hernia repair franchise including product design and development, market research, strategic planning, pricing, product.
• Exceeded 2009 revenue target, contributing 9% growth vs. 2008
• Achieved over $228 million sales through 2013 from internally developed products launched
• Achieved over $400 million sales through 2013 from acquired products launched since 2006

Warwick, RI, US

• Managed upstream/downstream product management team to drive growth in Bard’s highly profitable, market-leading hernia repair and fixation franchise.
• Executed five major product launches totaling over $189 million in new sales since launch
• Awarded 2006 Marketing MVP

Warwick, RI, US

• Full lifecycle PM responsibility for Davol’s market-leading Ventral Hernia Repair franchise
• Managed product line to a 13% average annual growth rate, reaching $118 million in 2006.
• Launched Biologics franchise with $22 million in year one and over $375 million through ‘13

Armonk, New York, NY, US

• Identified opportunities, sold projects, managed engagement teams, and maintained client relationships at major pharmaceutical, biotech, and medical product companies
• Developed U.S. pricing and contracting strategies for a $3 billion pharmaceutical product and a $1 billion pharmaceutical product portfolio, including analysis of various marketplace scenarios, design of complex market.
• Led global team in conducting a multi-country market assessment for a new biotech product, resulting in an overhaul of the company’s business strategy and product portfolio plans

Boston, MA, US

Managed $30 million line of apheresis equipment and supplies for the U.S. Blood Bank market.

Mba, Marketing & Management

Ab, Government

Biodesign Program, Managing Innovation